PT  - JOURNAL ARTICLE
AU  - Bulik, Sascha
AU  - Peters, Bjoern
AU  - Holzhütter, Hermann-Georg
TI  - Quantifying the Contribution of Defective Ribosomal Products to Antigen Production: A Model-Based Computational Analysis
AID  - 10.4049/jimmunol.175.12.7957
DP  - 2005 Dec 15
TA  - The Journal of Immunology
PG  - 7957--7964
VI  - 175
IP  - 12
4099  - http://www.jimmunol.org/content/175/12/7957.short
4100  - http://www.jimmunol.org/content/175/12/7957.full
SO  - J. Immunol.2005 Dec 15; 175
AB  - Antigenic peptides (epitopes) presented on the cell surface by MHC class I molecules derive from proteolytic degradation of endogenous proteins. Some recent studies have proposed that the majority of epitopes stem from so-called defective ribosomal products (DRiPs), i.e., freshly synthesized proteins that are unable to adopt the native conformation and thus undergo immediate degradation. However, a reliable computational analysis of the data underlying this hypothesis was lacking so far. Therefore, we have applied kinetic modeling to derive from existing kinetic data (Princiotta et al. 2003, Immunity 18, 343–354) the rates of the major processes involved in the cellular protein turnover and MHC class I-mediated Ag presentation. From our modeling approach, we conclude that in these experiments 1) the relative share of DRiPs in the total protein synthesis amounted to ∼10% thus being much lower than reported so far, 2) DRiPs may become the decisive source of epitopes within an early phase after onset of the synthesis of a long-lived (e.g., virus derived) protein, and 3) inhibition of protein synthesis by the translation inhibitor cycloheximide appears to be paralleled with an instantaneous decrease of protein degradation down to ∼1/3 of the normal value.